AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria. Prevention by antioxidant vitamins.
about
Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitorsMitochondrial toxin 3-nitropropionic acid induces cardiac and neurotoxicity differentially in miceAging and HIV/AIDS: pathogenetic role of therapeutic side effectsImmunomodulatory effect of zidovudine (ZDV) on cytotoxic T lymphocytes previously exposed to ZDVMitochondrial dna depletion, oxidative stress, and mutation: mechanisms of dysfunction from nucleoside reverse transcriptase inhibitors.Zidovudine induces downregulation of mitochondrial deoxynucleoside kinases: implications for mitochondrial toxicity of antiviral nucleoside analogs.Zidovudine (AZT) and hepatic lipid accumulation: implication of inflammation, oxidative and endoplasmic reticulum stress mediators.Lactic acidosis related to nucleoside therapy in HIV-infected patients.Absence of a universal mechanism of mitochondrial toxicity by nucleoside analogs.Mitochondrial disease in the offspring as a result of antiretroviral therapy.Relationship of Oxidative Stress with HIV Disease Progression in HIV/HCV Co-infected and HIV Mono-infected Adults in Miami.Skeletal muscle cellular metabolism in older HIV-infected men.Mitochondrial pathophysiology, reactive oxygen species, and cardiovascular diseasesOxidative imbalance in HIV-1 infected patients treated with antiretroviral therapy.Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV-infected mothers on antiretroviral therapyGenetic polymorphisms in SLC23A2 as predictive biomarkers of severe acute toxicities after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.Nucleoside reverse transcriptase inhibitor toxicity and mitochondrial DNA.Biogerontology in Spain: the most significant studies.Central role of mitochondria in drug-induced liver injury.Premature and accelerated aging: HIV or HAART?Oral antioxidants counteract the negative effects of female aging on oocyte quantity and quality in the mouse.AZT-induced oxidative cardiovascular toxicity: attenuation by Mg-supplementation.Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study.Increased oxidative stress condition found in different stages of HIV disease in patients undergoing antiretroviral therapy in Umuahia (Nigeria).Azidothymidine causes functional and structural destruction of mitochondria, glutathione deficiency and HIV-1 promoter sensitization.Nucleoside reverse transcriptase inhibitors impair endothelium-dependent relaxation by increasing superoxide.Transgenic mitochondrial superoxide dismutase and mitochondrially targeted catalase prevent antiretroviral-induced oxidative stress and cardiomyopathy.Possible differential induction of phase 2 enzyme and antioxidant pathways by american ginseng, Panax quinquefolius.Vitamins C and E prevent AZT-induced leukopenia and loss of cellularity in bone marrow. Studies in mice.
P2860
Q24536268-EBDF06D2-83C9-492E-8F1A-11F293EBCB77Q28360954-B7302278-9659-4BF6-A3EC-DF01CF2C8A98Q34089694-CB888D3F-C423-4EE6-8835-82DF291F5B57Q34113323-6BF727A3-9577-48DE-AF9E-386A6A59B319Q34282667-81319FB6-132B-4DFD-B4F5-E9A0F7209E75Q34436535-FBA88D17-8B7C-44AB-800E-FA0B06DC33FEQ35022972-21EEE268-BF7B-4ED0-992C-E28B2F084F0EQ35183747-190C073D-3934-46EB-910C-5D05E3AA50F5Q35879021-F39A200C-8857-4021-B8CA-74EFC59FC427Q36446890-A7D30409-0E63-414F-9E66-EA929F938D2AQ36680651-B24C0983-2377-4353-A5CF-7F2CFDFBE2D7Q36918744-AFF03DAC-CDD0-4149-BCAF-2CA6E5800138Q37076893-AA99D6B6-5965-4EF2-9D5C-366755C01C5DQ37400380-7515975A-2579-46E9-A847-176132AB6394Q37492507-CE5021C6-4831-4D5E-AD65-7C27094919AFQ37605384-29949992-0A25-429F-91AB-BFD74D68B391Q37798546-C3A32FFA-68EA-4F63-9AFE-D639E40692F9Q37820466-5D2571CB-6870-43C2-AC0F-A8195E31A023Q37926590-B472E52A-5D58-4D61-838C-EFB7F9684F76Q39474417-E3B45CAF-ABE7-4B9D-9A8E-B1FC7EA83485Q42164490-1AFA2633-AEE3-4A10-918D-D3845FD7CE86Q42454619-3FBACB4B-4F61-4CE9-8B18-ECABD39C9304Q43787821-E577E810-B206-4EE5-B804-77BCD4AE17A5Q43981054-06728EB1-D749-45E6-A894-5F501A55A1D9Q44016338-4FB79C90-B013-474C-94D6-1841DF20E1D0Q44185615-8EA013A2-6D17-4D2E-90AC-4B8A2663FDD4Q46034270-136A9A7F-7E2A-4574-AE53-BBCF471461F4Q46719094-CE41F01C-AC37-42B2-860B-3A81C7CFB28DQ53565339-EE9E9703-7616-42A9-8624-90FFEDB223C7
P2860
AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria. Prevention by antioxidant vitamins.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
AZT treatment induces molecula ...... ntion by antioxidant vitamins.
@en
AZT treatment induces molecula ...... ntion by antioxidant vitamins.
@nl
type
label
AZT treatment induces molecula ...... ntion by antioxidant vitamins.
@en
AZT treatment induces molecula ...... ntion by antioxidant vitamins.
@nl
prefLabel
AZT treatment induces molecula ...... ntion by antioxidant vitamins.
@en
AZT treatment induces molecula ...... ntion by antioxidant vitamins.
@nl
P2093
P2860
P356
P1476
AZT treatment induces molecula ...... ntion by antioxidant vitamins.
@en
P2093
Pallardó FV
de la Asunción JG
del Olmo ML
P2860
P356
10.1172/JCI1418
P407
P577
1998-07-01T00:00:00Z